Arvaya Healthcare Limited submitted a regulatory compliance statement to BSE Limited regarding fund utilization for the quarter ended June 30, 2026. The company stated that pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with applicable SEBI Circulars, the Statement of Deviation(s) or Variation(s) in utilisation of funds is not applicable to the Company for the quarter ended 30th June 2026.
The disclosure was signed by Kaushal Uttam Shah, Managing Director (DIN: 02175130), and digitally signed on August 12, 2026 at 20:00:31 +05:30. The communication was sent from Pune to the Corporate Relations Department of BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001.
The company requested BSE to take this information on record, confirming compliance with SEBI LODR regulations without any deviations or variations in fund utilization during the quarter.